BC
EW icon

Burney Company’s Edwards Lifesciences EW Stock Holding History

Burney Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
29,504
-17,735
-38% -$1.49M 0.07% 202
2026
Q1 		$3.78M Buy
47,239
+5,337
+13% +$440K 0.12% 150
2025
Q4 		$3.57M Buy
41,902
+1,412
+3% +$116K 0.11% 170
2025
Q3 		$3.15M Buy
40,490
+3,960
+11% +$309K 0.1% 178
2025
Q2 		$2.86M Buy
+36,530
New +$2.72M 0.1% 179
2024
Q1 		– Sell
-3,378
Closed -$258K – 604
2023
Q4 		$258K Sell
3,378
-875
-21% -$60.9K 0.01% 523
2023
Q3 		$295K Hold
4,253
– – 0.01% 482
2023
Q2 		$401K Buy
4,253
+235
+6% +$20.4K 0.02% 446
2023
Q1 		$332K Buy
+4,018
New +$316K 0.02% 470
2020
Q4 		– Sell
-3,285
Closed -$262K – 529
2020
Q3 		$262K Buy
3,285
+93
+3% +$7.26K 0.02% 433
2020
Q2 		$221K Hold
3,192
– – 0.01% 444
2020
Q1 		$201K Hold
3,192
– – 0.02% 407
2019
Q4 		$248K Sell
3,192
-150
-4% -$11.7K 0.01% 423
2019
Q3 		$245K Sell
3,342
-36
-1% -$2.53K 0.01% 406
2019
Q2 		$208K Hold
3,378
– – 0.01% 429
2019
Q1 		$215K Sell
3,378
-675
-17% -$38.5K 0.01% 429
2018
Q4 		$207K Hold
4,053
– – 0.01% 414
2018
Q3 		$235K Sell
4,053
-9,525
-70% -$466K 0.01% 409
2018
Q2 		$659K Sell
13,578
-390
-3% -$18.2K 0.04% 293
2018
Q1 		$650K Sell
13,968
-975
-7% -$42.3K 0.04% 270
2017
Q4 		$561K Sell
14,943
-1,284
-8% -$47.1K 0.03% 285
2017
Q3 		$589K Buy
16,227
+10,422
+180% +$397K 0.04% 266
2017
Q2 		$227K Buy
+5,805
New +$212K 0.01% 366
2016
Q4 		– Sell
-6,522
Closed -$262K – 387
2016
Q3 		$262K Buy
6,522
+150
+2% +$5.65K 0.02% 332
2016
Q2 		$212K Buy
+6,372
New +$218K 0.02% 352

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Burney Company's EW Position: Q2 2026 in Review

Burney Company reduced its Edwards Lifesciences (EW) stake by 38% in Q2 2026, selling an estimated $1.49M and leaving 29,504 shares worth $2.67M. The position accounts for 0.07% of the portfolio, ranked #202.

Burney Company first reported a position in EW in Q2 2016 and has held it in 25 quarters since. The position peaked at $3.78M in Q1 2026. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Burney Company held 29,504 shares of Edwards Lifesciences worth $2.67M as of Q2 2026.
  • Burney Company sold 17,735 Edwards Lifesciences shares in Q2 2026, an estimated $1.49M.
  • Edwards Lifesciences made up 0.07% of Burney Company's portfolio in Q2 2026, its #202 holding.
  • Burney Company first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 25 quarters since.
  • Burney Company's Edwards Lifesciences position peaked at $3.78M in Q1 2026.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.